Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, Robert J, Hutson, Thomas E, Cella, David, Reeves, James, Hawkins, Robert, Guo, Jun, Nathan, Paul, Staehler, Michael, de Souza, Paul, Merchan, Jaime R, Boleti, Ekaterini, Fife, Kate, Jin, Jie, Jones, Robert, Uemura, Hirotsugu, De Giorgi, Ugo, Harmenberg, Ulrika, Wang, Jinwan, Sternberg, Cora N, Deen, Keith, McCann, Lauren, Hackshaw, Michelle D, Crescenzo, Rocco, Pandite, Lini N, Choueiri, Toni K
Published in The New England journal of medicine (22.08.2013)
Published in The New England journal of medicine (22.08.2013)
Get full text
Journal Article
Incorporation of pazopanib in maintenance therapy of ovarian cancer
du Bois, Andreas, Floquet, Anne, Kim, Jae-Weon, Rau, Joern, del Campo, Josep M, Friedlander, Michael, Pignata, Sandro, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mirza, Mansoor R, Monk, Bradley J, Kimmig, Rainer, Ray-Coquard, Isabelle, Zang, Rongyu, Diaz-Padilla, Ivan, Baumann, Klaus H, Mouret-Reynier, Marie-Ange, Kim, Jae-Hoon, Kurzeder, Christian, Lesoin, Anne, Vasey, Paul, Marth, Christian, Canzler, Ulrich, Scambia, Giovanni, Shimada, Muneaki, Calvert, Paula, Pujade-Lauraine, Eric, Kim, Byoung-Gie, Herzog, Thomas J, Mitrica, Ionel, Schade-Brittinger, Carmen, Wang, Qiong, Crescenzo, Rocco, Harter, Philipp
Published in Journal of clinical oncology (20.10.2014)
Published in Journal of clinical oncology (20.10.2014)
Get full text
Journal Article
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
Gambacorti-Passerini, Carlo, Cortes, Jorge E, Lipton, Jeff H, Kantarjian, Hagop M, Kim, Dong-Wook, Schafhausen, Philippe, Crescenzo, Rocco, Bardy-Bouxin, Nathalie, Shapiro, Mark, Noonan, Kay, Leip, Eric, DeAnnuntis, Liza, Brümmendorf, Tim H, Khoury, H Jean
Published in Haematologica (Roma) (01.08.2018)
Published in Haematologica (Roma) (01.08.2018)
Get full text
Journal Article
Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia
Cortes, Jorge E, Muresan, Bogdan, Mamolo, Carla, Cappelleri, Joseph C, Crescenzo, Rocco J, Su, Yun, Gambacorti-Passerini, Carlo, Heeg, Bart, Douglas Smith, B
Published in Current medical research and opinion (02.09.2019)
Published in Current medical research and opinion (02.09.2019)
Get more information
Journal Article
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias
Kota, Vamsi, Brümmendorf, Tim H., Gambacorti-Passerini, Carlo, Lipton, Jeff H., Kim, Dong-Wook, An, Fiona, Leip, Eric, Crescenzo, Rocco J., Ferdinand, Roxanne, Cortes, Jorge E.
Published in Leukemia research (01.12.2021)
Published in Leukemia research (01.12.2021)
Get full text
Journal Article
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
Xu, Linlin, Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan, Burke, John M, Zafar, Syed F, Cultrera, Jennifer L, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Crescenzo, Rocco, By, Kunthel, Cohen, Aileen, Chen, Dih-Yih, Idoine, Adam, Manda, Sudhir, Sharman, Jeff P, Ramakrishnan, Vanitha
Published in Haematologica (Roma) (01.07.2024)
Published in Haematologica (Roma) (01.07.2024)
Get full text
Journal Article
Progression-free survival by local investigator versus independent central review: Comparative analysis of the AGO-OVAR16 Trial
Floquet, Anne, Vergote, Ignace, Colombo, Nicoletta, Fiane, Bent, Monk, Bradley J, Reinthaller, Alexander, Calvert, Paula, Herzog, Thomas J, Meier, Werner, Kim, Jae-Weon, del Campo, Josep M, Friedlander, Michael, Pisano, Carmela, Isonishi, Seiji, Crescenzo, Rocco J, Barrett, Catherine, Wang, Karrie, Mitrica, Ionel, du Bois, Andreas
Published in Gynecologic oncology (01.01.2015)
Published in Gynecologic oncology (01.01.2015)
Get full text
Journal Article
PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES
Tam, Constantine, Shadman, Mazyar, Sharman, Jeff, Cull, Gavin, Phillips, Tycel, Trotman, Judith, Cohen, Aileen, Allewelt, Heather, Crescenzo, Rocco, Delarue, Richard, Zhang, Heather, Tariq, Bilal, Sahasranaman, Sri, Ou, Ying C, Flinn, Ian W
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B‐CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
Shadman, Mazyar, Y. Levy, Moshe, Porter, Ryan, M. Burke, John, L. Cultrera, Jennifer, Misleh, Jamal, Sharman, Jeff, F. Zafar, Syed, By, Kunthel, Cohen, Aileen, Crescenzo, Rocco, Idoine, Adam, W. Flinn, Ian
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
OP112 Evaluation Of A Self-Administered Smart Phone-Based Application As A Wellness Measure In A Clinical Trial Of Zanubrutinib
Crescenzo, Rocco, Idoine, Adam, By, Kunthel, Yang, Keri
Published in International journal of technology assessment in health care (14.12.2023)
Published in International journal of technology assessment in health care (14.12.2023)
Get full text
Journal Article
Sonrotoclax (BGB-11417) in Combination with Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma with t(11;14): Safety, Efficacy, and Determination of Recommended Phase 2 Dose
Quach, Hang, Sborov, Doug, Kazandjian, Dickran, Spencer, Andrew, Low, Michael, Bal, Susan, Callander, Natalie S., Cheng, Huan, Patel, Sheel, Crescenzo, Rocco J., Agarwal, Amit, Dhakal, Binod
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Preliminary Safety of a Bcl-2 Inhibitor, Bgb-11417, in Patients with Relapsed/Refractory Multiple Myeloma Harboring t(11,14): A Non-Randomized, Open-Label, Phase 1b/2 Study
Quach, Hang, Rajagopal, Rajeev, Spencer, Andrew, Low, Michael, Kazandjian, Dickran, Crescenzo, Rocco, Du, Chenmu, Patel, Sheel, Mundra, Vaibhav, Cheng, Huan, Dhakal, Binod
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Prospective Biomarker Analysis of the Randomized CHER‐LOB Study Evaluating the Dual Anti‐HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2‐Positive Breast Cancer
Guarneri, Valentina, Dieci, Maria Vittoria, Frassoldati, Antonio, Maiorana, Antonino, Ficarra, Guido, Bettelli, Stefania, Tagliafico, Enrico, Bicciato, Silvio, Generali, Daniele Giulio, Cagossi, Katia, Bisagni, Giancarlo, Sarti, Samanta, Musolino, Antonino, Ellis, Catherine, Crescenzo, Rocco, Conte, PierFranco
Published in The oncologist (Dayton, Ohio) (01.09.2015)
Published in The oncologist (Dayton, Ohio) (01.09.2015)
Get full text
Journal Article
Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies
Shadman, Mazyar, Flinn, Ian W., Kingsley, Edwin C., Freeman, Benjamin B., Levy, Moshe, Farber, Charles M., D'Olimpio, James, Cultrera, Jennifer L., Zhang, Ben, Crescenzo, Rocco J., Idoine, Adam, Zhang, Xiaoping, By, Kunthel, Sharman, Jeff P.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Fatigue life assessment of wire arc additively manufactured ER100S-1 steel parts
Ermakova, Anna, Razavi, Nima, Crescenzo, Rocco, Berto, Filippo, Mehmanparast, Ali
Published in Progress in additive manufacturing (01.12.2023)
Published in Progress in additive manufacturing (01.12.2023)
Get full text
Journal Article
Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies
Shadman, Mazyar, Flinn, Ian W., Kingsley, Edwin C., Freeman, Benjamin, Levy, Moshe Yair, Holmes, Houston, Farber, Charles M., Chaudhry, Arvind, Crescenzo, Rocco, Idoine, Adam, Zhang, Xiaoping, Cohen, Aileen, By, Kunthel, Huang, Jane, Sharman, Jeff P.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Genomic Landscape of Ibrutinib- and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study
Xu, Linlin, Shadman, Mazyar, Flinn, Ian W., Levy, Moshe, Porter, Ryan, Burke, John M., Zafar, Syed F., Cultrera, Jennifer L., Misleh, Jamal, Kingsley, Edwin C., Yimer, Habte A., Freeman, Benjamin B., Chaudhry, Arvind, Tumula, Praveen K., Gandhi, Mitul, Crescenzo, Rocco J., By, Kunthel, Cohen, Aileen Cleary, Idoine, Adam, Manda, Sudhir, Sharman, Jeff P.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan F, Burke, John M, Zafar, Syed F, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Rao, Subramanya S, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Manda, Sudhir, Chen, Dih-Yih, By, Kunthel, Xu, Linlin, Liu, Ye, Crescenzo, Rocco, Idoine, Adam, Zhang, Xiaoping, Cohen, Aileen, Huang, Jane, Sharman, Jeff P
Published in The Lancet. Haematology (01.01.2023)
Published in The Lancet. Haematology (01.01.2023)
Get more information
Journal Article
Matching-Adjusted Indirect Treatment Comparison of Bosutinib, Dasatinib, Nilotinib and Ponatinib on Survival for Second Line Chronic Phase Chronic Myeloid Leukemia Patients
Muresan, Bogdan, Mamolo, Carla, Cappelleri, Joseph C., Shapiro, Mark, Crescenzo, Rocco J., Su, Yun, Heeg, Bart
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article